Clinical Trials Directory

Trials / Unknown

UnknownNCT05288192

Changes After Suprachoroidal Injection.

Changes Noted After Suprachoroidal Triamcinolone Acetonide Injection.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Benha University · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Changes after suprachoroidal injection are analyzed for statistical analysis.

Detailed description

Changes after suprachoroidal injection of triamcinolone acetonide are noted in various retinal diseases treated by this technique to address its effects over six months of follow-up.

Conditions

Interventions

TypeNameDescription
DRUGSuprachoroidal triamcinolone acetonide (SCTA) injectionSuprachoroidal injection of 4mg/0.1ml of triamcinolone acetonide.

Timeline

Start date
2022-02-15
Primary completion
2022-08-30
Completion
2022-09-01
First posted
2022-03-21
Last updated
2022-03-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05288192. Inclusion in this directory is not an endorsement.

Changes After Suprachoroidal Injection. (NCT05288192) · Clinical Trials Directory